XL TDR® Is an Investigational Device That May Be Right for You.
NuVasive® has developed a minimally disruptive surgical device called XL TDR for the treatment of DDD. Participants are now being enrolled in a clinical research study for this total disc replacement device. The study is intended to evaluate the device's safety and effectiveness.
What Is XL TDR?
XL TDR is a metallic prosthetic joint, or total disc replacement, that replaces a degenerative intervertebral disc. Like fusion, total disc replacement is designed to supplant the primary function of the disc – to maintain vertebral spacing to protect the nerves and spinal cord. Unlike fusion, though, total disc replacement seeks to maintain one of the secondary functions of the disc – providing motion in the spine. Once implanted between the vertebrae, XL TDR is designed to relieve pain and restore height while replicating the motion characteristics of an intact healthy disc.
Where Is the XL TDR Clinical Research Study Being Conducted?
There are clinical research study sites located nationwide. Read more about this clinical research study at
Home - ClinicalTrials.gov. This multi-center clinical research study is a prospective, controlled trial designed to evaluate the safety and efficacy of XL TDR by comparing outcomes of patients with this device to literature-reported results of similar devices that have been approved by the FDA to treat disc degeneration.